NIH-funded research R01 grant

Risk factors for alpha-gal allergy and tick bites in people with Anderson-Fabry disease

Official title: Risk factors of alpha-gal syndrome: investigating the human genetic risk factors and the tick salivary sensitizer

Funded at Kansas State University · NIH-11456513 · Data updated 2026-11-12

A research project investigates why some people, including those with Anderson-Fabry disease, develop alpha-gal allergy after a tick bite and how genetics and tick saliva contribute.

More Risk Factors research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionKansas State University
NIH-funded
Lab location1 site (Manhattan, United States)
Project startAugust 10, 2026
Project endJuly 31, 2031
Funding year2026
Award (this year)$662,390
NIH project number1R01AI193623-01A1
Project IDNIH-11456513 on NIH RePORTER

Who could benefit from this research

Could help

Adults with or at risk for alpha-gal syndrome, and individuals with a history of tick exposure or Anderson-Fabry disease who may be affected by AGS.

Less likely to help

Individuals without tick exposure or alpha-gal allergy may not benefit from this research.

What this research studies

This grant studies why certain individuals become allergic to red meat after a tick bite, focusing on human genetics and the tick’s saliva. It combines genetic analyses with examination of tick salivary components to understand who is at risk. The project uses patient samples and human data to identify genetic variants and biochemical factors that may increase susceptibility and severity of alpha-gal syndrome.

Why it matters

Potential benefit: If successful, it could lead to better risk screening and personalized precautions for people at risk of alpha-gal allergy.

How similar studies have gone: Preliminary findings have linked genetic and biochemical factors to AGS, but larger validating studies are needed.

Where this research is happening

  • Kansas State University
    Manhattan, United States
    Active

Researchers

  • Principal investigator: Park, Yoonseong — Kansas State University
  • Study coordinator: Park, Yoonseong

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.